General Information of Drug (ID: DMTXNZK)

Drug Name
Icofungipen Drug Info
Synonyms
PLD-118; 198022-65-0; UNII-I20202Q8M8; BAY-10-8888; I20202Q8M8; Cyclopentanecarboxylic acid, 2-amino-4-methylene-, (1R,2S)-; Icofungipen [INN]; (1R,2S)-2-Amino-4-methylene-cyclopentanecarboxylic acid; PLD118; PLD 118; 156292-16-9; BAY 10-8888; (1r,2s)-2-amino-4-methylidenecyclopentanecarboxylic acid; AC1Q5QVF; AC1L50CI; 2-amino-4-methylenecyclopentane-1-carboxylic acid; SCHEMBL117349; CHEMBL343803; CTK0H0639; DTXSID90173515; RKOUGZGFAYMUIO-RITPCOANSA-N; (1R,2S)-2-amino-4-methylidenecyclopentane-1-carboxylic acid; Icofungipen [INN]; (1R,2S)-2-Amino-4-methylenecyclopentane-1-carboxylic acid; AHMA
Indication
Disease Entry ICD 11 Status REF
Fungal infection 1F29-1F2F Phase 2 [1]
Therapeutic Class
Antifungal Agents
Cross-matching ID
PubChem CID
216240
CAS Number
CAS 198022-65-0
TTD Drug ID
DMTXNZK

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Discontinued Drug(s)
Drug(s) Targeting DNA topoisomerase (TOP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Karenitecin DMCRGY4 Lung cancer 2C25.0 Phase 3 [3]
TOPOSTATIN DMNZQO9 Discovery agent N.A. Investigative [4]
6-(3-Ethyl-phenylamino)-1H-pyrimidine-2,4-dione DMKUHN9 Discovery agent N.A. Investigative [5]
N*4*-Benzyl-6-chloro-pyrimidine-2,4-diamine DMNGSQK Discovery agent N.A. Investigative [6]
5-Bromo-6-p-tolylamino-1H-pyrimidine-2,4-dione DMTPRIW Discovery agent N.A. Investigative [6]
6-Benzylamino-1H-pyrimidine-2,4-dione DM8FUZL Discovery agent N.A. Investigative [6]
6-(3-Bromo-phenylamino)-1H-pyrimidine-2,4-dione DMMFWYX Discovery agent N.A. Investigative [5]
6-(Indan-5-ylamino)-1H-pyrimidine-2,4-dione DMSH107 Discovery agent N.A. Investigative [5]
6-Benzylamino-5-bromo-1H-pyrimidine-2,4-dione DMGJYWF Discovery agent N.A. Investigative [6]
2-Amino-6-(indan-5-ylamino)-3H-pyrimidin-4-one DMECHD0 Discovery agent N.A. Investigative [6]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
CB-102930 DMZ3QHF Bacterial infection 1A00-1C4Z Terminated [7]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
DNA topoisomerase (TOP) TT2GPK3 NOUNIPROTAC Inhibitor [2]
Fungal Isoleucyl t-RNA synthetase (Fung ILS1) TTBZHDM SYIC_YEAST Modulator [1]

References

1 Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits. Antimicrob Agents Chemother. 2005 May;49(5):2084-92.
2 Crystallization and preliminary X-ray analysis of anti-cancer agent 3-(9-acridinylamino)-5-(hydroxymethyl)aniline complexed with the DNA hexamer d(CGTACG)2. Biochim Biophys Acta. 2003 Jan 3;1625(1):27-9.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Isoaurostatin, a novel topoisomerase inhibitor produced by Thermomonospora alba. J Nat Prod. 2001 Feb;64(2):204-7.
5 Inhibitors of Bacillus subtilis DNA polymerase III. 6-Anilinouracils and 6-(alkylamino)uracils. J Med Chem. 1980 Jan;23(1):34-8.
6 Inhibitors of Bacillus subtilis DNA polymerase III. Influence of modifications in the pyrimidine ring of anilino- and (benzylamino)pyrimidines. J Med Chem. 1986 May;29(5):676-81.
7 Prospects for Aminoacyl-tRNA Synthetase Inhibitors as New Antimicrobial Agents. Antimicrob Agents Chemother. 2005 December; 49(12): 4821-4833.